Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
Liangqing Dong(Fudan University), Dayun Lu(Chinese Academy of Sciences), Ran Chen(Chinese Academy of Sciences), Youpei Lin(Fudan University), Hongwen Zhu(Chinese Academy of Sciences), Zhou Zhang(Burning Rock Biotech (China)), Shangli Cai(Burning Rock Biotech (China)), Peng Cui(Burning Rock Biotech (China)), Guohe Song(Fudan University), Dongning Rao(Fudan University), Xinpei Yi(Baylor College of Medicine), Yingcheng Wu(Fudan University), Nixue Song(Chinese Academy of Sciences), Fen Liu(Chinese Academy of Sciences), Yunhao Zou(Chinese Academy of Sciences), Shu Zhang(Fudan University), Xiaoming Zhang(University of Ottawa), Xiaoying Wang(Fudan University), Shuang‐Jian Qiu(Fudan University), Jian Zhou(Fudan University), Shisheng Wang(Sichuan University), Xu Zhang(University of Ottawa), Yongyong Shi(Shanghai Jiao Tong University), Daniel Figeys(University of Ottawa), Li Ding(James S. McDonnell Foundation), Pei Wang(Icahn School of Medicine at Mount Sinai), Bing Zhang(Baylor College of Medicine), Henry Rodriguez(National Institutes of Health), Qiang Gao(Fudan University), Daming Gao(Chinese Academy of Sciences), Hu Zhou(Chinese Academy of Sciences), Jia Fan(Fudan University)
Cited by 410